BRIJ Medical

BRIJ Medical, founded in 2018, has developed and commercialized the Brijjit Force Modulating Tissue Bridge, a novel medical device that actively offloads tension from surgical incisions to promote better healing. The company targets the plastic and reconstructive surgery, orthopedic surgery, and urgent care markets with a product clinically demonstrated to significantly reduce wound breakdown and scar size. BRIJ Medical operates as a commercial-stage, private company, generating revenue through direct sales of its FDA-cleared Class I medical device to healthcare providers and systems.

Active Tension Offloading via a non-invasive, biocompatible tissue bridge placed on the skin to modulate forces around a healing incision.

Competes against traditional wound closure methods (sutures, staples, adhesives like 2-Octyl Cyanoacrylate) and advanced wound care products. Key differentiators are its active tension-offloading mechanism, non-invasive application, and multi-day wear for scar therapy. Faces competition from large medtech conglomerates and specialized scar management companies, but its unique biomechanical approach creates a distinct niche.